Table 2.
Main demographic data, clinical characteristics and lung function parameters of patients
Study population | |||
---|---|---|---|
N | % | ||
Number of patients | 12743 | 100 | |
Number of cases in regions of Hungary | East | 5149 | 40.4 |
West | 3984 | 31.3 | |
Central | 3610 | 28.3 | |
Examined patients according to seasonality | April–September | 6923 | 54.3 |
October–March | 5820 | 45.7 | |
Years since the diagnosis of asthma | 0–1 years | 310 | 2.4 |
2–5 years | 3280 | 25.7 | |
6–10 years | 3295 | 25.9 | |
11–20 years | 3930 | 30.8 | |
>20 years | 1913 | 15.0 | |
No data | 15 | 0.1 | |
GINA based treatment categories | STEP 1 | 274 | 2.15 |
STEP 2 | 990 | 7.77 | |
STEP 3 | 4759 | 37.35 | |
STEP 4 | 6390 | 50.14 | |
STEP 5 | 330 | 2.59 | |
Gender | Male | 4059 | 31.9 |
Female | 8684 | 68.1 | |
Smoking habit | Smoker | 1669 | 13.1 |
Former smoker | 2584 | 20.3 | |
Never smoked | 8476 | 66.5 | |
No data | 14 | 0.1 | |
Age distribution | 18–30 | 1261 | 9.9 |
31–45 | 2466 | 19.4 | |
46–65 | 5687 | 44.6 | |
>65 | 3329 | 26.1 | |
Body mass index distribution | <18.5 | 228 | 1.8 |
18.5–24.9 | 3453 | 27.1 | |
25–29.9 | 4487 | 35.2 | |
30–34.9 | 3009 | 23.6 | |
≥35 | 1566 | 12.3 | |
FEV1 (forced expiratory volume in 1 s, % predicted) distribution | >80% | 7527 | 59.1 |
60–80% | 3399 | 26.7 | |
<60% | 1461 | 11.5 | |
No data | 356 | 2.8 |
Abbreviation: GINA, global initiative for asthma.